EastPharma Ltd. announced revenue results for the nine months of 2013. For the period, the company's revenue in the nine months of 2013 was USD 164.1 million, down 3.9% from USD 170.8 million for the same period in 2012. The company's sales decrease was mainly driven by decreased volumes in DEVA's Veterinary business.